News | March 27, 2014

Atherotech Opens Patient Service Center in Sarasota, Fla.

Physician open house marks availability of comprehensive VAP+ Lipid Panel cholesterol testing to Sarasota and Bradenton area physicians and patients

March 27, 1014 — Atherotech Diagnostics Lab opened its patient service center in Sarasota, Fla. A physician open house in November celebrated the opening of the center 4014 Sawyer Road, Sarasota, Fla.

The new center enables area physicians and medical practices to send patients directly to the service center for the VAP± Lipid Panel comprehensive cholesterol profile instead of having to go through third-party laboratory service centers. This patient service center will be staffed by Atherotech professionals, who will provide high quality patient care and specimen collection.

“This brings the physician and patient closer to the VAP+ Lipid Panel, making it convenient for area residents and their providers to access the most comprehensive assessment of heart disease risk and subsequent prevention strategies available,” said Atherotech Vice President of business operations Alan Hokanson.

Hokanson said the center adds to the growing number of Atherotech patient service centers nationwide to keep up with increasing demand for the VAP+ Lipid Panel.

The Sarasota location will be open Monday through Friday from 7:30 a.m. to 4:30 p.m. Patients with a physician’s order simply visit the center and provide a blood draw, which is then sent directly to Atherotech’s laboratory in Birmingham, Ala., for processing.

For more information: www.Atherotech.com

Related Content

Alere point of care POC testing for INR
News | Point of Care Testing| July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is on
Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)

Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.

Feature | Point of Care Testing| May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios
Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on fi
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing| April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing| April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
highly sensitive troponin testing
News | Cardiac Diagnostics| March 21, 2017
March 21, 2017 — A blood test for a protein called high-sensitivity troponin T, which is released into the bloodstrea
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing| March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing| January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...

The Xprecia Stride Coagulation Analyzer delivers fast, reliable prothrombin time/international normalized ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist. It is the latest INR testing system to enter the market in late 2016. Read the article “Siemens Receives FDA Clearance of Xprecia Stride Coagulation Analyzer.”
 

 

Feature | Point of Care Testing| December 30, 2016 | Ravi Chawat
Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology
Overlay Init